title: Identification of an aminothiazole with antifungal activity against intracellular Histoplasma capsulatum.
abstract: As eukaryotes, fungi possess relatively few molecules sufficiently unique from mammalian cell components to be used as drug targets. Consequently, most current antifungals have significant host cell toxicity. Primary fungal pathogens (e.g., Histoplasma) are of particular concern, as few antifungals are effective in treating them. To identify additional antifungal candidates for the treatment of histoplasmosis, we developed a high-throughput platform for monitoring Histoplasma growth and employed it in a phenotypic screen of 3,600 commercially available compounds. Seven hit compounds that inhibited Histoplasma yeast growth were identified. Compound 41F5 has fungistatic activity against Histoplasma yeast at micromolar concentrations, with a 50% inhibitory concentration (IC50) of 0.87 μM, and has the greatest selectivity for yeast (at least 62-fold) relative to host cells. Structurally, 41F5 consists of an aminothiazole core with an alicyclic substituent at the 2-position and an aromatic substituent at the 5-position. 41F5 inhibits Histoplasma growth in liquid culture and similarly inhibits yeast cells within macrophages, the actual host environment of this fungal pathogen during infection. Importantly, 41F5 protects infected host cells from Histoplasma-induced macrophage death, making this aminothiazole hit compound an excellent candidate for development as an antifungal for Histoplasma infections.
authors.affiliation: Department of Microbiology and Department of Microbial Infection and Immunity, Ohio State University, Columbus, Ohio, USA.
authors.forename: Jessica A
authors.initials: JA
authors.lastname: Edwards
authors.forename: Megan M
authors.initials: MM
authors.lastname: Kemski
authors.forename: Chad A
authors.initials: CA
authors.lastname: Rappleye
mesh_terms: D000818:Animals; D000935:Antifungal Agents / Q000737:chemistry / Q000494:pharmacology*; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D017930:Genes, Reporter; D022781:Hepatocytes / Q000187:drug effects / Q000382:microbiology; D057166:High-Throughput Screening Assays; D006658:Histoplasma / Q000187:drug effects* / Q000254:growth & development; D006801:Humans; D007763:Lac Operon; D008264:Macrophages / Q000187:drug effects / Q000382:microbiology; D051379:Mice; D008826:Microbial Sensitivity Tests; D009281:Naphthalenes / Q000737:chemistry / Q000494:pharmacology*; D054852:Small Molecule Libraries / Q000737:chemistry / Q000494:pharmacology*; D013844:Thiazoles / Q000737:chemistry / Q000494:pharmacology*
chemical_list: C587547:41F5 compound; D000935:Antifungal Agents; D009281:Naphthalenes; D054852:Small Molecule Libraries; D013844:Thiazoles